Physician profile
Ankur Saini
NPI 1144529397
$3,185.49
in general payments reported to CMS, 2019-2025
24 companies · $889 in 2025
The $889 reported for 2025 was more than what a typical Sleep Medicine (Internal Medicine) provider received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $103 · 2020: $20.58 · 2021: $37.45 · 2022: $143 · 2023: $1,489 · 2024: $503 · 2025: $889.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,840 · Travel and Lodging: $871 · Education: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,840.15 |
| Travel and Lodging | $870.97 |
| Education | $169.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Respicardia, INC. | $1,292.24 | 2023-2024 | Remede System |
| Astrazeneca Pharmaceuticals LP | $612.95 | 2023-2025 | Fasenra, Airsupra, Tezspire |
| Jazz Pharmaceuticals INC. | $381.05 | 2019-2025 | |
| Harmony Biosciences LLC | $321.75 | 2022-2025 | Wakix |
| Inspire Medical Systems, INC. | $105.29 | 2024-2025 | Inspire |
| Merck Sharp & Dohme LLC | $56.04 | 2025 | Winrevair |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.51 | 2025 | Ofev |
| Avadel Cns Pharmaceuticals, LLC | $34.65 | 2024-2025 | Lumryz |
| Axsome Therapeutics, INC. | $32.03 | 2023-2025 | Sunosi |
| United Therapeutics Corporation | $28.94 | 2025 | |
| Glaxosmithkline, LLC. | $28.54 | 2024 | Nucala |
| Regeneron Healthcare Solutions, INC. | $27.68 | 2024-2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $24.36 | 2025 | Glassia |
| Insmed, INC. | $23.60 | 2024 | Arikayce |
| Verona Pharma, INC. | $21.51 | 2025 | Ohtuvayre |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $20.83 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.58 | 2020 | |
| Pfizer INC. | $20.12 | 2021 | |
| Mallinckrodt Hospital Products INC. | $19.39 | 2023 | Acthar |
| Actelion Pharmaceuticals US, INC. | $18.23 | 2025 | Opsynvi, Uptravi |
| Boston Scientific Corporation | $17.33 | 2021 | |
| Lilly USA, LLC | $14.88 | 2025 | Mounjaro |
| Amgen INC. | $14.29 | 2024 | Tezspire |
| Itamar Medical INC | $11.70 | 2023 | Watchpatone |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ankur Saini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.